may miss week
note provid expect
cover compani morgan healthcar confer may
investor question regard elect scenario believ investor focu
remain individu compani perform next week med-tech histor trade
well elect cycl economi strong procedur growth steadi
robust flu season inact congress unlik chang individu
compani dynam pertin next week biggest risk med-tech
stock view high expect go given dynam
think compani provid guidanc conserv set
pullback see like scenario wherebi compani provid
preliminari revenu choos forego guidanc later quarter
base histor preced expect preannounc multipl
zimmerman buy pt thibault
expect beat think could deliv anoth nice beat stabl
open surgeri procedur continu out-performance atriclip expect
guidanc initi conserv frame revenu growth
given share run late could disappoint bullish
investor tail end robust look pois anoth strong
beat demand strain suppli capac recent report
think dxcm guidanc bracket perhap come higher
street rel conserv expect believ result
could top sell-sid expect recent stock run buy-sid
expect seem higher analyst estim set high bar
seen relief ralli late eas comp improv sinuva
reimburs set think modest expect share could
continu higher slightli better expect result base busi
benefit particularli easi comp strengthen spine
market combin us hardwar momentum see beat like
share move higher continu confid new product contribut
buy weak revenu guidanc may come
expect would use pullback accumul
like long-term dynam see sustain growth
could bit volatil usual start year conserv
procedur guidanc expect combin competit
introduct believ share could pullback depend competit
commentari confer lastli uncertain
pre-announce see guidanc lower expect
increasingli competit mig market attent avedro integr
companytickerr price presentationd timeour presentationneutralalfonsotuesday januari pst typic pre-announc depart ceo mile white previous express comfort revenu growth last earn call possibl may reiter confid long-term revenu growth goal assum libr approv anticip investor focu timelin well marque product like portico look commentari nutrit segment given recent challeng china mitraclip commentari remain bullish particularli around potenti reimburs function mitral regurgit lastli capit alloc remain front center investor mind present preannouncepres preannouncepres preannounceneutralalfonsomonday januari pst histor pre-announc result might fare comp eas busi lend favor set-up in-lin result minimum yet result light last quarter modest growth protect pci street model revenu factor uptick impella sale issu highlight recent vascular complic may take quarter resolv frankli flattish perform last three quarter make us unsur believ thing get better time aggress effort rectifi busi train educ bear fruit head potenti pre-announce howev say certainti street forecast met besid updat procedur look perspect educ train effort progress japan timelin enrol stemi dtu trial present pre-announce revenu rais guidanc present pre-announce revenu rais guidanc present preannouncedneutralthibaultwednesday januari pst pre-announce financi reaffirm guidanc pre-announce expect pre-announce year compani choos provid preliminari result would look revenu gross order age-out cancel expect order growth revenu revenu convers consist result remain import investor normal present -- new financi provid re-affirmed guidanc present press releas present preliminari result present pre-announce press releas
companytickerr price presentationd timeour presentationalcneutralzimmermantuesday januari pstgiven first year larg multi-n public compani typic report top bottom line believ compani want take addit time gather full financi addit alc work larg enterpris wide project may prohibit time financi gather least first year said management meet investor analyst confer investor interest increas alc given share pull back follow result saw higher expect spend lower om guidanc regardless pre-announce see top-lin beat like comp across variou segment similar alc beat top-lin said om guidanc come follow believ focu remain alc abil drive margin expans ultim ep public compani time public compani time public compani time atrcbuy ptalfonsothursday januari pstwe expect pre-announc initi guidanc overal feel good given upbeat management commentari recent confer track record consist beat top-lin estim street look revenu growth rang believ achiev ytd revenu growth averag close support atriclip growth near consist open ablat growth high-singl digit although atriclip grow bigger number cost-effect eas use drive momentum addit label claim electr isol could refin market pitch open ablat growth stabl continu uptak driven addit train societi guidelin awar management like guid conserv begin bracket consensu revenu growth besid guidanc expect focu converg timelin pathway ebitda profit product pipelin present pre-announce provid preliminari outlookpres pre-announce provid preliminari outlookpres pre-announce provid preliminari outlookbuy ptzimmermanthursday januari pstsimilar previou year expect pre-announce less certain management provid guidanc year histori miss expect believ like management choos wait call better understand busi track provid initi guidanc said management meet analyst investor may provid addit commentari see in-lin print like abl beat expect signific absolut dollar amount street look rel similar dynam present pre-announce preliminari revenu miss btig/consensu estim maintain guidanc time later lower year progress present pre-announce report preliminari revenu reiter guidanc expect revenu growth present pre-announce report preliminari revenu reiter guidanc expect revenu growth
companytickerr price presentationd timeour presentationbsxbuy ptalfonsotuesday januari pstconsist last year expect gener overview busi high-level target upcom fiscal year manag previous commit deliv oper margin improv double-digit ep growth recent earn call management reiter confid target de-risk stock ahead formal guidanc offer februari present like focu key growth driver opportun emerg market oper leverag anticip upbeat commentari upcom marque launch exalt acur neo lotu edg japan investor remain focus structur health outlook mainli around plan full lotu edg commerci roll-out eu pre-announc revenu provid oper goal key metric revenu oper margin ep growth present -- new financi providednorm present -- new financi providedneutralzimmermanthursday januari pstwe expect present necessarili see compani preannounc note btig/consensu expect call revenu midst cfo search fda warn letter may posit speak quarterli financi time confer addit note recent file compani still work aetna resolut polici deni compon product given clear expect sale result hamper dynam amongst variou issu present pre-announce report preliminari revenu top btig/consensu provid guidanc time pre-announce present pre-announce report preliminari revenu establish revenu guidanc pre-announce neutralthibaultmonday januari pstwe expect pre-announce revenu present guidanc repeat outperform throughout demand nearli outstrip suppli time report would surpris beat model y/i growth consensu y/i growth post anoth out-performance consensu estim look especi doabl howev current valuat think expect alreadi account share price share doubl valu follow think investor expect strong achiev guidanc least bracket consensu excel beat beyond guidanc expect investor focus sustain enthusiast patient demand potenti time abbott libr price headwind time data updat progress toward limit market releas late pre-announce provid guidanc present pre-announce provid guidanc present pre-announce provid guidanc
companytickerr price presentationd timeour presentationewneutralalfonsomonday januari pstwe expect gener present new financi given compani host comprehens investor day decemb within management commentari anticip bullish tone around tavr market power on-going low-risk ramp well continu optim around mitral opportun management may press thought around competit ahead aggress lotu launch eu potenti mid-year launch abbott portico roll-out acur neo eu also expect focu pascal ramp eu litig litig number key trial germani would curiou around potenti settlement think like scenario normal present -- new financi providednorm present -- new financi providednorm present -- new financi providedneutralzimmermannot presentingw expect meet interest investor analyst also expect pre-announce revenu provid preliminari thought around guidanc new management formul new busi strategi coupl pre-announce potenti reset could see share move higher investor believ plan achiev present pre-announce public compani time public compani time elgxbuy ptthibaultthursday januari pstwhile elgx pre-announce revenu result re-affirmed guidanc laid revenu expect last year unusu circumst follow restructur announc month earlier expect manag offer preliminari result revenu guidanc around year confer topic may includ detail regard anticip ce mark fda regulatori clearanc ovat alto end respect custom fda reaction kaiser data progress compani clinic trial importantli fda confirmatori studi nellix present pre-announce reiter guidanc set revenu guidanc normal present -- new financi provid normal present -- new financi provid
companytickerr price presentationd timeour presentationestabuy ptalfonsonot presentingesta schedul present outlook forward-year commentari like reserv februari investor call call anticip focu outlook updat enrol reconstruct cohort earli thought minim invas procedur japan investor also remain watch cash use need increment financ present pre-announce public compani time public compani time neutralzimmermanwednesday januari pstsimilar previou year expect present confer expect financi announc relat expect guidanc come call also expect clinic data updat expect conserv guid rel street expect believ multipl variabl includ avedro integr competit mig market slow mig market result numer variabl pre-announce present pre-announce financi result announc interim data idos travoprost multi-cent random double-blind ph studi present pre-announce neutralzimmermannot presentingw expect pre-announce result present typic season strongest expect top emerg expect street estim reason view btig/consensu estim call revenu consensu emerg sale believ may also provid preliminari guidanc consensu current estim revenu see fairli in-lin may come share ralli sinc call see share fairli valu believ expect buy-sid may higher analyst estim set high bar come present pre-announce preliminari revenu top btig/consensu estim also establish preliminari guidanc non-gaap ep present pre-announce report preliminari revenu establish guidanc revenu non-gaap ep pre-announce report preliminari revenu establish guidanc sale fx headwind ep
companytickerr price presentationd timeour presentationbuy ptzimmermanmonday januari pstwe believ present pre-announce preliminari revenu aesthet busi remov believ investor focu return legaci product line market opportun new product enhanc within legaci busi unit share ralli follow cynosur divestitur sit near high end price-to-earnings multipl believ need deliv strong preliminari revenu number move share higher present pre-announce announc preliminari revenu compar guid rang btig/consensu estim present pre-announce announc preliminari revenu compar guid rang btig/consensu estim present pre-announce neutralthibaulttuesday januari pstwe expect pre-announce result give guidanc around event expect discuss expect timelin major mileston investor may interest get updat progress horizon pivot plan commerci announc appoint new cfo reiter revenu guidanc normal present -- new financi provid normal present -- new financi provid buy ptzimmermanwednesday januari pstwe expect integra present pre-announce preliminari revenu btig/consensu estim call revenu management guidanc call revenu organ growth call css ott think like could exceed expect combin easier comp combin increas contribut new product disrupt competit acquisit orthoped competit challeng wound set succeed pre-announce report preliminari revenu vs btig/consensu also provid commentari organ growth end slightli result end organ growth y/i present pre-announce report preliminari revenu organ growth ep exceed guidanc codman derma scienc notabl standout perform present pre-announce announc acquisit derma scienc dsci report revenu organ growth ep midpoint guidanc rang
companytickerr price presentationd timeour presentationneutralzimmermanwednesday januari pstwith new management team place ceo cfo less certain pre-announce previou year see potenti pre-announce order allay investor concern think investor focu updat commerci strategi core busi sinuva better expect result provid modest relief ralli share current multipl concern management transit rep may somewhat district current quarter investor focu like whether sinuva j-code valu incentiv physician usag note present pre-announce report preliminari revenu compar btig/consensu estim also gave initi guidanc pre-announce report preliminari revenu compar btig/consensu estim also gave initi guidanc present pre-announce report preliminari revenu compar btig/consensu estim also gave initi guidanc januari pstwe would expect provid preliminari revenu well breakdown segment also expect provid procedur growth management suggest would guid januari earn call late januari uncertain give procedur growth rang confer momentum ytd believ investor look procedur growth tend guid conserv start year would expect wider rang begin year like someth closer street expect slightli present pre-announce report preliminari revenu compar btig/consensu estim also report preliminari instrument system servic revenu compani also report preliminari procedur volum unit placement pre-announce report preliminari revenu compar btig/consensu estim also report preliminari instrument system servic revenu compani also report preliminari procedur volum unit placement pre-announce report preliminari revenu compar btig/consensu estim also report preliminari instrument system servic revenu compani also report preliminari procedur volum unit placement ptalfonsomonday januari pstwith recent tweak guidanc anticip surpris accompani confer straightforward present like present anticip management touch continu growth zio xt salesforc traction partnership verili discuss around transit categori code limit given lack real updat though management tone like remain bullish around prospect stabl higher reimburs present preannouncepres pre-announce present pre-announce
companytickerr price presentationd timeour presentationlivnneutralalfonsonot presentinglivanova schedul present besid outlook investor focus organiz chang post caisson termin timelin recov trend tandemlif long-term invest continu topic interest especi sinc caisson exit free cash present pre-announce present pre-announce present pre-announce neutralthibaultnot presentingw expect financials-rel announc around confer anticip compani continu wait formal earn call discuss guidanc outlook normal present -- new financi provid normal present -- new financi provid normal present -- new financi provid buy ptzimmermanmonday januari pstgiven histori see unlik provid preliminari revenu estim anticip present said management bullish growth expect driven new product introduct eas comp consensu expect call revenu adj ep equat growth report xfx growth ep growth pre-announce present pre-announce present pre-announce
companytickerr price presentationd timeour presentationbuy ptzimmermanthursday januari pstwe expect meet interest investor analyst expect pre-announce key dynam busi profil launch nexu within surgic channel well rep product gain within wound believ import drive revenu higher management suggest last earn call distribut agreement progress think updat would meaning also believ metric provid may show nexu demand could help lift share higher given share drift downward ye present pre-announce present pre-announce present pre-announce buy ptalfonsonot present schedul present pre-announc revenu last year management previous guid revenu growth midpoint street model potenti upsid think boil quickli success salesforc spur treatment session demand among earli adopt one reason behind shortfal sens management take right step effect target issu plan dtc effort help share trade near cash point see minim downsid risk apart major chang forward-year outlook predict investor sentiment improv busi challeng eas reason guidanc set and/or evid quarterli beat possibl japan present pre-announce public compani time public compani time buy ptzimmermanwednesday januari pstwe uncertain whether would pre-announce last year given ceo chri barri short tenur time ultim compani pre-announce ahead present expect similar set-up year expect provid revenu necessarili offer guidanc consensu expect call revenu ep given momentum see share also us hardwar growth would expect good print comp us hardwar low set scenario exceed expect present pre-announce pre-announce preliminari revenu vs btig/consensu estim guidanc provid call late februari present pre-announce report preliminari revenu establish guidanc msd revenu growth bp omx ebitda present pre-announce report full year result preliminari outlook revenu oper margin expans expect
companytickerr price presentationd timeour presentationoblnbuy ptzimmermannot presentingobln attend conferencedid present pre-announce present pre-announce present pre-announce buy ptzimmermannot presentingw expect meet interest investor analyst expect pre-announce come recent equiti offer believ investor curiou understand intend use capit consensu expect call revenu reflect declin level result loss pass-through statu believ recent capit infus scale sale forc may mitig impact reimburs cut larger unit volum public compani time public compani time public compani time neutralzimmermannot presentingwith new ceo challeng comp present confer believ unlik pre-announce year current btig/consensu estim call revenu guidanc call revenu btig/consensu ep estim call guidanc new management expect conserv guidanc slightli concern management chang could impact sale focu remain cautiou around major busi one bright spot could surpris upsid depend launch disc go share could ralli bullish commentari pre-announce report preliminari revenu y/i roughli in-lin btig consensu estim respect segment report biostim biolog exfix spinefix respect initi offici guidanc say compani target msd revenu growth double-digit organ revenu growth pre-announce report preliminari revenu establish guidanc includ posit fx impact off-set neg impact decreas market fee mtf biolog present pre-announce report preliminari revenu segment introduc guidanc
companytickerr price presentationd timeour presentationbuy ptzimmermannot presentingw expect pre-announce ahead investor analyst meet btig/consensu call revenu expect initi guidanc call march move see comp beatabl given trauma slowdown seen move past would expect challeng comp recent capit rais abl add instrument set field support grow demand acknowledg multipl high make expect challeng beat current level present pre-announce report preliminari revenu y/i top btig/consensu expect initi guidanc march present pre-announce report preliminari revenu compani announc guidanc public compani time buy ptzimmermannot present pre-announce preliminari revenu vs consensu addit management provid preliminari guidanc ahead suggest doubl digit growth provid strong guidanc rel consensu estim note spinal implant growth exceed present pre-announce report preliminari revenu y/i top btig/consensu estim initi revenu guidanc present pre-announce report preliminari revenu establish revenu guidanc present pre-announce revenu rang ptthibaultnot presentingw expect pre-announce guidanc around confer present present present pre-announce preliminari revenu set guidanc via press releas
companytickerr price presentationd timeour presentationbuy ptzimmermannot presentingw expect pre-announce revenu provid initi thought guidanc ahead meet investor consensu call revenu y/i expect revenu growth fall closer base cadenc growth management spoken multi-year basi would use pullback share begin accumul posit expect increas growth outer year follow initi conserv guidanc recent note ide approv us pivot trial evo within us think updat around enrol time would seen posit expect rapid enrol pace could ultim put evo us market sooner initi expect present pre-announce announc revenu consensu guidanc provid call march present pre-announce present pre-announce buy ptzimmermannot presentingmgmt indic plan attend confer due numer sale meet addit on-go integr effort relat pend acquisit wright medic expect neither pre-announce comment around time confer investor may read neg note present pre-announce last year confer instead choos host nation sale meet time present pre-announce present pre-announce report preliminari revenu ep high end previous state guidanc pre-announce report preliminari revenu ep high end ye guidanc ptzimmermannot presentingw expect pre-announce prior meet investor current btig/consensu estim call revenu expect guid typic give earn call even go road management late less certainti around result histori management limit see numer growth driver airwear head neck sale forc optim management reiter sustain grower would conceiv put floor guidanc present pre-announce report preliminari revenu y/i top consensu estim come btig estim present pre-announce report preliminari revenu y/i top btig/consensu estim present pre-announce report preliminari revenu y/i top btig/consensu estim
companytickerr price presentationd timeour presentationvlrxneutralthibaultnot presentingw expect announc valerita follow revenu guidanc reduct late decemb plan explor strateg altern includ sale compani chapter possibl vlrx may offer updat regard potenti progress suppli disrupt led reduct guidanc anticip impact sale present present pre-announce preliminari revenu result present buy ptthibaultnot presentingw expect pre-announce around confer anticip guidanc offer formal report march present yet public compani yet public compani buy ptthibaultmonday januari pstwe expect give normal present new financi expect discuss relat outlook long-term revenu growth margin well increas import softwar servic emerg market non-hardwar product normal present -- new financi provid normal present -- new financi provid normal present -- distribut ratio corp spin-off given via press releas
companytickerr price presentationd timeour presentationbuy ptzimmermannot present typic provid preliminari revenu guidanc ahead confer compani meet interest investor analyst see unlik provid updat call investor wil look lead commentari around biopsi convers rate surgeon penetr base histor procedur per physician level concern maci expect may high recogn strong line sight procedur pipelin biopsi concern may unfound said see in-lin print best case scenario present pre-announce present pre-announce present pre-announce buy ptthibaultnot presentingw think like pre-announce revenu order compani done last two year howev note present interim cfo possibl chang revenu guidanc reiter earli decemb expect compani meet consensu expect forecast gross order like higher mani investor expect order consensu -- three analyst -- call gross order recent focu compani abil instal system time fashion think revenu investor main focu report cash usag also like remain import investor guid cash usag achiev rang import us given compani rel high cash burn rate present pre-announce revenu order present pre-announce preliminari revenu order present buy ptzimmermannot presentinggiven momentum ye increas import rosa overal improv growth compani actual believ higher liklihood preannounc year said management present uncertain need management town meet investor consensu call revenu ep pre-announce present pre-announce present pre-announce report preliminari sale report adjust net ldrh bill day fx divestitur
btig cover compani mention report
appendix analyst certif import disclosur
